Glut1 was efficiently deleted in vivo, and Glut1 protein levels were sharply reduced in B-ALL cells purified from splenocytes of tamoxifen-treated recipient animals (Figure 6b). Here, SLC2A1 is linked to precursor B-cell acute lymphoblastic leukemia.